Guardant Health raises 2026 revenue outlook to $1.30B-$1.32B as Shield targets 230,000-245,000 tests

Fluor misses Q1 estimates

Ono Pharmaceutical reports FY results

Skyward sees $30M-$35M 2026 fee income as Apollo scales managed premiums

Corsair forecasts Q2 2026 revenue $295M-$320M with non-GAAP EPS $0.05-$0.07 while reaffirming full-year guidance